New Zealand markets close in 5 hours 40 minutes

Sonoma Pharmaceuticals, Inc. (SNOA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
3.7000-0.0700 (-1.86%)
At close: 04:00PM EST
3.6300 -0.07 (-1.89%)
After hours: 05:07PM EST
Full screen
Loading interactive chart…
  • Business Wire

    Sonoma Pharmaceuticals Announces Expansion of its Partner Network for Oral and Dental Products in the U.S. and China

    WOODSTOCK, Ga., January 20, 2022--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing patented Microcyn® technology-based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound, eye, oral and nasal care, disinfectant use and dermatological conditions, today announced that it has added Salus Medical as an additional distribution partner in the United States for dental care and expanded its oral and dental care li

  • Business Wire

    Sonoma Pharmaceuticals to Present at H.C. Wainwright BioConnect Virtual Conference January 10-13, 2022

    WOODSTOCK, Ga., January 05, 2022--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions, today announced that it will be featured as a presenting company at the H.C. Wainwright BioConnect Conference. The conference is being held on January 10-13, 2022 virtually.

  • Business Wire

    Sonoma Pharmaceuticals Reports Second Quarter FY 2022 Financial Results

    WOODSTOCK, Ga., November 15, 2021--Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA), a global healthcare leader developing and producing stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, nasal care, oral care and dermatological conditions today announced financial results for its second fiscal quarter and six months ended September 30, 2021.